相关实验视频

Updated: Jan 9, 2026

A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact

A Test Bed to Examine Helmet Fit and Retention and Biomechanical Measures of Head and Neck Injury in Simulated Impact

Published on: September 21, 2017

儿童道路交通伤害的流行病学:加纳的一项多中心医院研究

Anthony Baffour Appiah¹, Michael Lowery Wilson², Peter Dambach³

¹Heidelberg Institute of Global Health, University of Heidelberg, Im Neuenheimer Feld 130.3, Heidelberg, 69120, Germany. anthony.baffour_appiah@stud.uni-heidelberg.de.

Injury epidemiology

|December 2, 2025

概括

道路交通伤害 (RTIs) 在加纳不成比例地影响儿童和青少年,伤害类型和死亡率的区域差异很大. 有针对性的道路安全干预措施对于解决这些差异和减少儿童死亡率至关重要.

科学领域:

儿科伤害流行病学儿科伤害流行病学
公共卫生和公共安全.
预防道路交通事故伤害

背景情况:

道路交通伤害 (RTI) 构成了全球严重的健康威胁,尤其对儿童和青少年来说.
加纳的道路交通死亡人数呈上升趋势,与西方国家的下降率形成鲜明对比.
了解儿科RTI特征和模式对于有效的干预至关重要.

研究的目的:

检查加纳儿童道路交通伤害 (RTI) 病例的伤害特征.
分析儿科RTI病例和住院患者死亡的时空模式.
确定加纳三个地理区域的儿科RTI的区域差异.

主要方法:

从2021-2024年对加纳三个教学医院的儿科RTI病例进行了回顾性横截面研究.
对社会人口统计,时空,伤害类型,严重程度和结果数据的分析.
利用描述性统计,奇平方测试和量子地理信息系统 (QGIS) 来绘制地图.

主要成果:

分析了1,485例儿科RTI病例;男孩 (72.3%) 和青少年 (13-18岁) 受影响最多.
步行者撞倒 (51.1%) 和摩托车撞击 (33.2%) 是主要原因,区域差异很大.
死亡率因地区而异:北部6.9%,南部2.8%,中部0%

结论:

在加纳的儿科RTI模式,事故类型和死亡率方面存在显著的区域差异.
目前的道路安全干预措施在全国范围内似乎具有有限的有效性.
建议包括加强道路安全教育,执法和基础设施改进,包括专门的行人路线.

关键词:

青少年是一个青少年.孩子孩子孩子孩子地理信息系统地理信息系统这里是加拿大加拿大加拿大加拿大.道路交通事故发生的原因创伤性脑损伤是一种创伤性脑损伤.

更多相关视频

A Multi-Modal Approach to Assessing Recovery in Youth Athletes Following Concussion

A Multi-Modal Approach to Assessing Recovery in Youth Athletes Following Concussion

Published on: September 25, 2014

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

A Pediatric Concussion Model in Mice: Closed Head Injury with Long-Term Disorders (CHILD)

Published on: February 7, 2025

相关概念视频

Introduction to Epidemiology

Introduction to Epidemiology

Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...

Pharmacokinetics in Pediatric Patients: Drug Metabolism

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...

Pharmacokinetics in Pediatric Patients: Drug Distribution

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...